Argan Inc
AGX NYSE Construction - Special Trade Contractors Financials FY2017βFY2026
What Argan Inc does
No business description yet.
- Legal name
- ARGAN INC
- Fiscal year ends
- January 31, 2026
- Latest annual report
- 10-K Β· Mar 26, 2026
- Accession Β· CIK
- 0001104659-26-035216
0000100591
Revenue and margins
Argan Inc had $945M of revenue in fiscal 2026, up 8.1% on the year before.
Net income and earnings per share
From fiscal 2017 to 2026, diluted EPS grew 9.0% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $411M in fiscal 2026, 43.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Argan Inc returned $34.2M to shareholders in fiscal 2026, 8% of free cash flow. The diluted share count rose 1.7%.
Balance sheet
Cash, debt and the ratios that show how comfortably Argan Inc can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $350M | $325M | $307M | $298M | $491M |
| Current ratio | 2.3x | 2.2x | 1.8x | 1.6x | 1.6x |
| Quick ratio | 2.3x | 2.2x | 1.8x | 1.6x | 1.6x |
| Total assets | $554M | $489M | $598M | $836M | $1.2B |
| Total liabilities | $228M | $209M | $307M | $484M | $724M |
| Shareholders' equity | $326M | $281M | $291M | $352M | $462M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 8 | 4 / 8 | 3 / 8 | 6 / 8 | 6 / 8 | 3 / 8 | 5 / 8 | 6 / 8 | 5 / 8 |
| Accruals ratio | β29.3% | 24.4% | 32.2% | β20.0% | β27.9% | 1.7% | 12.1% | β15.5% | β11.5% | β27.4% |
| Altman Z'' | 5.24 | 8.28 | 11.91 | 6.66 | 5.30 | 6.52 | 6.54 | 5.32 | 4.98 | 4.88 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $675M | $893M | $482M | $239M | $392M | $509M | $455M | $573M | $874M | $945M |
| Provision for credit losses | β | β | β | $0.0M | $0.0M | $2.4M | $0.1M | β | β | β |
| Gross profit | $147M | $149M | $82.4M | β$6.8M | $62.1M | $99.7M | $86.4M | $80.8M | $141M | $194M |
| Operating income | $112M | $107M | $40.2M | β$55.8M | $23.0M | $44.5M | $41.7M | $36.5M | $88.2M | $135M |
| Pretax income | $115M | $113M | $47.2M | β$47.8M | $24.9M | $47.1M | $46.0M | $48.9M | $111M | $161M |
| Income tax | $37.1M | $40.3M | β$4.7M | β$7.1M | $1.1M | $11.4M | $11.3M | $16.6M | $25.7M | $22.7M |
| Net income | $70.3M | $72.0M | $52.0M | β$42.7M | $23.9M | $38.2M | $33.1M | $32.4M | $85.5M | $138M |
| Diluted EPS | $4.50 | $4.56 | $3.32 | β$2.73 | $1.51 | $2.40 | $2.33 | $2.39 | $6.15 | $9.74 |
| Diluted shares | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B | 0.01B | 0.01B | 0.01B | 0.01B |
| Cash flow | ||||||||||
| Cash from operations | $259M | β$72.8M | β$112M | $53.6M | $176M | $28.4M | β$30.1M | $117M | $168M | $415M |
| Capital expenditure | $2.8M | $4.8M | $8.6M | $7.1M | $1.7M | $1.4M | $3.4M | $2.8M | $6.6M | $3.9M |
| Free cash flow | $256M | β$77.6M | β$121M | $46.5M | $174M | $27.0M | β$33.4M | $114M | $161M | $411M |
| Depreciation and amortization | $2.0M | $2.8M | $3.4M | $3.5M | $3.7M | $3.4M | $3.0M | $2.0M | $1.9M | $1.9M |
| Stock-based compensation | $2.3M | $4.7M | $1.6M | $2.1M | $2.9M | $3.5M | $4.0M | $4.5M | $4.5M | $7.9M |
| Share buybacks | β | β | β | β | β | $20.4M | $68.2M | $12.5M | $1.5M | $9.9M |
| Dividends paid | β | β | β | β | $47.0M | $15.7M | $14.0M | $14.7M | $18.3M | $24.3M |
| Dividends and buybacks | β | β | β | β | $47.0M | $36.0M | $82.2M | $27.1M | $19.8M | $34.2M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $167M | $122M | $164M | $167M | $367M | $350M | $325M | $307M | $298M | $491M |
| Current assets | $588M | $485M | $416M | $422M | $546M | $507M | $439M | $547M | $781M | $1.1B |
| Current liabilities | $351M | $183M | $81.3M | $144M | $276M | $223M | $203M | $302M | $480M | $711M |
| Property and equipment, net | $13.1M | $15.3M | $19.8M | $22.5M | $20.4M | $10.5M | $10.4M | $11.0M | $14.5M | $16.6M |
| Goodwill | $34.9M | $34.3M | $32.8M | $27.9M | $27.9M | $28.0M | $28.0M | $28.0M | $28.0M | $28.0M |
| Intangible assets | $8.2M | $7.1M | $6.1M | $5.0M | $4.1M | $3.3M | $2.6M | $2.2M | $1.8M | $1.5M |
| Total assets | $644M | $543M | $477M | $488M | $603M | $554M | $489M | $598M | $836M | $1.2B |
| Total liabilities | $352M | $185M | $82.3M | $147M | $280M | $228M | $209M | $307M | $484M | $724M |
| Shareholders' equity | $292M | $358M | $395M | $339M | $321M | $326M | $281M | $291M | $352M | $462M |
| Margins | ||||||||||
| Gross margin | 21.7% | 16.7% | 17.1% | β2.9% | 15.8% | 19.6% | 19.0% | 14.1% | 16.1% | 20.5% |
| Operating margin | 16.6% | 12.0% | 8.3% | β23.4% | 5.9% | 8.7% | 9.2% | 6.4% | 10.1% | 14.3% |
| EBITDA margin | 16.9% | 12.3% | 9.1% | β21.9% | 6.8% | 9.4% | 9.8% | 6.7% | 10.3% | 14.5% |
| Net margin | 10.4% | 8.1% | 10.8% | β17.9% | 6.1% | 7.5% | 7.3% | 5.6% | 9.8% | 14.6% |
| FCF margin | 38.0% | β8.7% | β25.1% | 19.5% | 44.4% | 5.3% | β7.3% | 19.9% | 18.4% | 43.5% |
| Returns | ||||||||||
| Return on capital employed | 38.2% | 29.8% | 10.2% | β16.3% | 7.1% | 13.5% | 14.5% | 12.3% | 24.7% | 28.4% |
| Return on equity | 24.1% | 22.2% | 13.8% | β11.6% | 7.2% | 11.8% | 10.9% | 11.3% | 26.6% | 33.8% |
| Return on assets | 10.9% | 12.1% | 10.2% | β8.9% | 4.4% | 6.6% | 6.3% | 5.9% | 11.9% | 13.6% |
| Return on tangible equity | 28.3% | 22.7% | 14.6% | β13.9% | 8.3% | 13.0% | 13.2% | 12.4% | 26.5% | 31.8% |
| Growth | ||||||||||
| Revenue growth | β | 32.3% | β46.0% | β50.4% | 64.1% | 29.9% | β10.7% | 26.0% | 52.5% | 8.1% |
| Net income growth | β | 2.4% | β27.7% | β182.0% | β | 60.3% | β13.5% | β2.2% | 164.1% | 61.2% |
| EPS growth | β | 1.3% | β27.2% | β182.2% | β | 58.9% | β2.9% | 2.6% | 157.3% | 58.4% |
| FCF growth | β | β130.3% | β | β | 274.8% | β84.5% | β223.9% | β | 41.1% | 155.2% |
| Share count change | β | 1.0% | β0.6% | β0.5% | 1.3% | 0.6% | β10.9% | β4.4% | 2.6% | 1.7% |
| Financial health | ||||||||||
| Current ratio | 1.7x | 2.6x | 5.1x | 2.9x | 2.0x | 2.3x | 2.2x | 1.8x | 1.6x | 1.6x |
| Quick ratio | 1.7x | 2.6x | 5.1x | 2.9x | 2.0x | 2.3x | 2.2x | 1.8x | 1.6x | 1.6x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.4% | 0.5% | 1.8% | 3.0% | 0.4% | 0.3% | 0.7% | 0.5% | 0.8% | 0.4% |
| Stock comp / revenue | 0.3% | 0.5% | 0.3% | 0.9% | 0.7% | 0.7% | 0.9% | 0.8% | 0.5% | 0.8% |
| Payouts / FCF | β | β | β | β | 27.0% | 133.5% | β | 23.8% | 12.3% | 8.3% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 4.0 | 3.0 | 6.0 | 6.0 | 3.0 | 5.0 | 6.0 | 5.0 |
| Altman Z'' | 5.2 | 8.3 | 11.9 | 6.7 | 5.3 | 6.5 | 6.5 | 5.3 | 5.0 | 4.9 |
| Accruals ratio | β29.3% | 24.4% | 32.2% | β20.0% | β27.9% | 1.7% | 12.1% | β15.5% | β11.5% | β27.4% |
Source: SEC EDGAR XBRL filings (CIK 0000100591). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.